Patient Experiences and Clinical Care of Basal and Squamous Cell Carcinomas Treatment Delays in the Setting of COVID-19
The Wehner Laboratory at The University of Texas MD Anderson Cancer Center is conducting a study to understand patient experiences and clinical care of patients with nonmelanoma skin cancer whose treatment has been delayed due to the COVID-19 pandemic.
We are conducting a 15-minute survey with shorter monthly follow-up surveys.
Patients who have been diagnosed with Basal Cell Carcinoma (BCC) or Squamous Cell Carcinoma (SCC) and have had treatment delayed due to COVID-19, can click here to participate.
For questions, or to learn more, please reach out to the research coordinator at CLHinkston@mdanderson.org or call 713-792-6979. For participant's rights questions, contact 713-792-6477.